HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of matrix metalloproteinase activity disrupts reconsolidation but not consolidation of a fear memory.

Abstract
The reconsolidation hypothesis posits that memories that have been reactivated can be either enhanced or disrupted by pharmacological manipulation. Synaptic plasticity is presumed to underlie the reconsolidation process. Matrix metalloproteinases are proteins that regulate the extracellular matrix involved in plasticity events, and these proteins have recently been shown to influence learning and memory. However, all studies on the role of matrix metalloproteinases in learning and memory have employed tasks that rely on contextual cues. The goal of this study was to determine the extent to which FN-439 would disrupt the consolidation and/or reconsolidation of a fear memory associated with a conditioned stimulus that signaled tone-shock pairings and that was independent of contextual cues. Male Sprague-Dawley rats were given infusions of FN-439 (35 microg intracerebroventricular) 30 min prior to conditioning (tone-shock paired association) or 30 min prior to a single reactivation session given 24h after conditioning. Administration of FN-439 did not disrupt consolidation of the freezing response when the tone (conditioned stimulus) was presented. In contrast, FN-439 infusion disrupted reconsolidation of the fear memory in a reactivation-dependent manner. The reduced freezing behavior was not due to a decrease in general anxiety levels, since FN-439 had no effect on the percent of open-arm time or open-arm entries in an elevated-plus maze task. Thus, we demonstrated for the first time that matrix metalloproteinase inhibition in the brain is capable of disrupting the reconsolidation of a tone-shock association memory that does not depend on contextual cues. The finding that a fear response to a previously paired conditioned stimulus can be disrupted by treatment with an MMP inhibitor during a single reactivation session suggests that this class of compounds may have therapeutic potential for posttraumatic stress disorder and/or simple phobias.
AuthorsTravis E Brown, Adrianne R Wilson, Davelle L Cocking, Barbara A Sorg
JournalNeurobiology of learning and memory (Neurobiol Learn Mem) Vol. 91 Issue 1 Pg. 66-72 (Jan 2009) ISSN: 1095-9564 [Electronic] United States
PMID18824238 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid
  • Hydroxamic Acids
  • Matrix Metalloproteinase Inhibitors
  • Oligopeptides
  • Matrix Metalloproteinases
Topics
  • Analysis of Variance
  • Animals
  • Anxiety (drug therapy)
  • Catheterization
  • Conditioning, Classical
  • Cues
  • Electroshock
  • Escape Reaction (drug effects)
  • Fear
  • Freezing Reaction, Cataleptic (drug effects)
  • Hearing
  • Hydroxamic Acids (pharmacology)
  • Male
  • Matrix Metalloproteinase Inhibitors
  • Matrix Metalloproteinases (metabolism)
  • Memory (drug effects, physiology)
  • Microinjections
  • Oligopeptides (pharmacology)
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: